跳至主要内容
临床试验/NCT01574118
NCT01574118终止2 期

Enhancing Exposure Therapy for PTSD: An Investigation of Non-Pharmacological Augmentation Strategies

University of Texas at Austin2 个研究点 分布在 1 个国家目标入组 27 人开始时间: 2012年4月最近更新:
适应症

试验速览

阶段
2 期
状态
终止
入组人数
27
试验地点
2
主要终点
Change from baseline in PTSD symptom severity

研究概览

简要总结

This study is investigating a new brief psychotherapy for post-traumatic stress disorder (PTSD) which, modifies an already proven psychotherapy for PTSD by adding two new components and modifying several others. The goal of the study is to determine whether this experimental treatment outperforms the well-established standard treatment.

详细描述

This study is investigating a new brief psychotherapy for post-traumatic stress disorder (PTSD) which, modifies an already proven psychotherapy for PTSD by adding two new components and modifying several others. The goal of the study is to determine whether this experimental treatment outperforms the well-established standard treatment. Individuals between the ages of 18-65 with chronic PTSD are randomly assigned to one of three psychotherapy conditions: (a) brief enhanced exposure therapy; (b) standard prolonged exposure therapy; and (c) delayed standard exposure therapy. All study participants undergo a phone and face-to-face screening assessment to determine study eligibility and baseline (pretreatment-Week 0) symptom severity. Upon completing treatment, participants undergo three additional assessment visits (Week 6, Week 10, and Week 22). During each of these outcome assessment visits, participants complete a structured clinical interview and a battery of computer-administered questionnaires.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Current primary PTSD diagnosis based on DSM-IV criteria, with a minimum duration of 12 weeks since the traumatic event.
  • Between the age of 18 and
  • Medication status stable for at least 6 weeks

排除标准

  • Current diagnosis of schizophrenia, delusional disorder, or organic mental disorder as defined by the DSM-IV.
  • Current diagnosis of bipolar disorder, depression with psychotic features, or depression severe enough to require immediate psychiatric treatment (i.e., serious suicide risk with intent and plan).
  • Current diagnosis of alcohol or substance dependence within the 3 previous months.
  • Unwilling or unable to discontinue current trauma-focused psychotherapy.
  • Ongoing intimate relationship with the perpetrator (in assault-related PTSD cases).
  • Other severe acute or chronic medical or psychiatric condition that, in the judgment of the Medical Director, would make the participant inappropriate for entry.

结局指标

主要结局

Change from baseline in PTSD symptom severity

时间窗: Weeks 6, 10, 22

PTSD Symptom Scale - Interview Version

次要结局

  • Change from baseline in trauma-related cognitions(Weeks 6, 10, 22.)
  • Change from baseline in work, social/leisure activities, and family/home life functioning(Weeks 6, 10, 22.)
  • Change from baseline in general physical and psychological health(Weeks 6, 10, 22)
  • Change from baseline in depression symptom severity(Weeks 6, 10, 22.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Michael J. Telch

Principal Investigator

University of Texas at Austin

研究点 (2)

Loading locations...

相似试验